TERMINAL HALF-LIVES OF DRUGS STUDIED IN PATIENTS WITH HEPATIC DISEASES

被引：8

作者：

CLOSSON, RG ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,SAN FRANCISCO,CA 94143

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1977年 / 34卷 / 05期

关键词：

D O I：

10.1093/ajhp/34.5.520

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：520 / 524

页数：5

共 59 条

[1] KINETICS OF RIFAMPICIN AND ISONIAZID ADMINISTERED ALONE AND IN COMBINATION TO NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASE [J].

ACOCELLA, G ;

BONOLLO, L ;

TENCONI, LT ;

GARIMOLDI, M ;

MAINARDI, M ;

NICOLIS, FB .

GUT, 1972, 13 (01) :47-+

[2] GROSS IMPAIRMENT OF HEPATIC DRUG-METABOLISM IN A PATIENT WITH CHRONIC LIVER-DISEASE [J].

ADJEPONYAMOAH, KK ;

NIMMO, J ;

PRESCOTT, LF .

BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5941) :387-388

[3]

ALVIN J, 1975, J PHARMACOL EXP THER, V192, P224

[4]

ANDERSON RJ, 1976, CLINICAL USE DRUGS R

[5] EFFECT OF CIRRHOSIS ON DISPOSITION AND ELIMINATION OF CLINDAMYCIN [J].

AVANT, GR ;

SCHENKER, S ;

ALFORD, RH .

AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1975, 20 (03) :223-230

[6]

AZZOLLINI F, 1972, INT J CLIN PHARM TH, V6, P130

[7]

BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO

[8]

2-M

[9] GUIDE TO DRUG-THERAPY IN RENAL-FAILURE [J].

BENNETT, WM ;

SINGER, I ;

COGGINS, CJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (11) :1544-1553

[10]

BLASCHKE TF, 1975, CLIN PHARMACOL THER, V17, P685

← 1 2 3 4 5 6 →